IGF2BP3 Antikörper (AA 1-100)

Produktnummer ABIN7156360

Produktdetails anti-IGF2BP3 Antikörper

Target: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Bindungsspezifität: AA 1-100

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser IGF2BP3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human, Maus

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Insulin-like growth factor 2 mRNA-binding protein 3 protein (1-100AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu IGF2BP3

Target: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Andere Bezeichnung: IGF2BP3 (IGF2BP3 Produkte)

Synonyme: CT98 antikoerper, IMP-3 antikoerper, IMP3 antikoerper, KOC1 antikoerper, VICKZ3 antikoerper, Ab2-255 antikoerper, RGD1306512 antikoerper, imp3 antikoerper, koc1 antikoerper, vera antikoerper, imp-3 antikoerper, vg1rbp antikoerper, vickz3 antikoerper, 2610101N11Rik antikoerper, AA522010 antikoerper, AL022933 antikoerper, AU045931 antikoerper, Koc13 antikoerper, Neilsen antikoerper, mimp3 antikoerper, dvr1rbp antikoerper, wu:fb79c12 antikoerper, wu:fe06h09 antikoerper, zVg1RBP antikoerper, B3 antikoerper, IGF2 mRNA-binding protein 3-B antikoerper, IMP antikoerper, IMP-3-B antikoerper, Vg1 RBP-B antikoerper, Vg1-RBP antikoerper, igf2bp3 antikoerper, igf2bp3-a antikoerper, igf2bp3-b antikoerper, IGF2 mRNA-binding protein 3-A antikoerper, IMP-3-A antikoerper, Vg1 RBP-A antikoerper, vera-A antikoerper, insulin like growth factor 2 mRNA binding protein 3 antikoerper, insulin-like growth factor 2 mRNA binding protein 3 antikoerper, insulin like growth factor 2 mRNA binding protein 3 S homeolog antikoerper, insulin like growth factor 2 mRNA binding protein 3 L homeolog antikoerper, IGF2BP3 antikoerper, Igf2bp3 antikoerper, igf2bp3 antikoerper, igf2bp3.S antikoerper, igf2bp3.L antikoerper

Hintergrund:

Background: RNA-binding factor that may recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript \\\'caging\\\' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3\\\'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to beta-actin/ACTB and MYC transcripts. Binds to the 5\\\'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs.

Aliases: Cancer/testis antigen 98 antibody, CT98 antibody, DKFZp686F1078 antibody, hKOC antibody, IF2B3_HUMAN antibody, IGF II mRNA binding protein 3 antibody, IGF-II mRNA-binding protein 3 antibody, IGF2 mRNA binding protein 3 antibody, IGF2 mRNA-binding protein 3 antibody, IGF2BP3 antibody, IMP 3 antibody, IMP-3 antibody, Insulin like growth factor 2 mRNA binding protein 3 antibody, Insulin-like growth factor 2 mRNA-binding protein 3 antibody, KH domain containing protein overexpressed in cancer antibody, KH domain-containing protein overexpressed in cancer antibody, KOC 1 antibody, KOC1 antibody, VICKZ 3 antibody, VICKZ family member 3 antibody, VICKZ3 antibody

UniProt: O00425